Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression | Nature Immunology
Cells | Free Full-Text | PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208
ectopic expression of MSX1 induced cell-cycle g1/s arrest and... | Download Scientific Diagram
Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis | PLOS ONE
Frontiers | Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy
G1/S cell cycle transition in normal and tumoral cells. G1/S transition... | Download Scientific Diagram
Frontiers | Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
The current markers of cancer stem cell in oral cancers - ScienceDirect
IJMS | Free Full-Text | B7 Family Members in Pancreatic Ductal Adenocarcinoma: Attractive Targets for Cancer Immunotherapy
An OFF–ON Two-Photon Fluorescent Probe for Tracking Cell Senescence in Vivo | Journal of the American Chemical Society
Senescence markers in human GH-producing pituitary adenomas. (A)... | Download Scientific Diagram
![PDF] Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a309508e062cbf2202977800a3574dc9cea4a0c3/4-Figure1-1.png "PDF] Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma | Semantic Scholar")
PDF] Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma | Semantic Scholar
Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading | Cell Death & Disease
Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis | PLOS ONE
JCM | Free Full-Text | Immunohistochemical Expression of CD44, MMP-2, MMP-9, and Ki-67 as the Prognostic Markers in Non-Clear Cell Renal Cell Carcinomas—A Prospective Cohort Study
Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma | British Journal of Cancer
Breast Cancer Targeting Peptide Binds Keratin 1: A New Molecular Marker for Targeted Drug Delivery to Breast Cancer | Molecular Pharmaceutics
Challenges in treatment of a patient suffering from neuroendocrine tumor G1 of the hilar bile duct: a case report | BMC Gastroenterology | Full Text
Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer - ScienceDirect
Frontiers | Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment | Nature Communications
Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies - ScienceDirect
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma | Nature Communications
Nanomedicines Targeting Glioma Stem Cells | ACS Applied Materials & Interfaces
Frontiers | Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation
Sequential fate-switches in stem-like cells drive the tumorigenic trajectory from human neural stem cells to malignant glioma | Cell Research
